HDAC6 and AL amyloidosis: In multiple myeloma, ACY-1215 has a specific inhibitory effect on HDAC6 activity: even a very low dose can induce potent acetylation of α-tubulin, but triggering the acetylation of lysine on histone H3 and histone H4 needs higher doses.